Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19.
Journal: Frontiers in immunology
Published: April 19, 2021
Opportunities and Challenges in Developing a Cryptosporidium Controlled Human Infection Model for Testing Antiparasitic Agents.
Journal: ACS infectious diseases
Published: April 06, 2021
Predicting the Immunogenicity of T cell epitopes: From HIV to SARS-CoV-2.
Journal: bioRxiv : the preprint server for biology
Published: June 09, 2020
Maintenance of Viral Suppression in Human Immunodeficiency Virus Controllers Despite Waning T-Cell Responses During Antiretroviral Therapy.
Journal: The Journal of infectious diseases
Published: December 21, 2019
Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell Transplantation.
Journal: Antimicrobial agents and chemotherapy
Published: December 16, 2019
Antiretroviral Therapy Reduces T-cell Activation and Immune Exhaustion Markers in Human Immunodeficiency Virus Controllers.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: January 24, 2019
A First-in-Human Study To Assess the Safety and Pharmacokinetics of LYS228, a Novel Intravenous Monobactam Antibiotic in Healthy Volunteers.
Journal: Antimicrobial agents and chemotherapy
Published: December 12, 2018
A proof-of-concept-to-confirmatory multiple adaptation design in the development of an anti-viral treatment.
Journal: Statistical methods in medical research
Published: October 31, 2018
Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1.
Journal: The Journal of clinical investigation
Published: November 06, 2017
Fine-mapping of genetic loci driving spontaneous clearance of hepatitis C virus infection.
Journal: Scientific reports
Published: May 09, 2017
A First-in-Human Study To Assess the Safety and Pharmacokinetics of Monoclonal Antibodies against Human Cytomegalovirus in Healthy Volunteers.
Journal: Antimicrobial agents and chemotherapy
Published: November 06, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026